Full Text View
Tabular View
No Study Results Posted
Related Studies
Postanesthesia Cognitive Recovery and Neuropsychologic Complications
This study is currently recruiting participants.
Verified by University of Roma La Sapienza, May 2007
First Received: July 23, 2007   Last Updated: July 24, 2007   History of Changes
Sponsored by: University of Roma La Sapienza
Information provided by: University of Roma La Sapienza
ClinicalTrials.gov Identifier: NCT00507195
  Purpose

The study proposes to analyze the difference in the rapidity of the recovery of post operative cognition immediately after extubation and 20, 40 and 60 minutes post extubation and neuropsychological complications (delirium) after 48 hours following general anesthesia using a prospective, randomized approach. Patients undergoing any type of surgery with the exception of cranial, cardiac or thoracic surgery can be enrolled in the study.


Condition Intervention
Anesthesia Recovery Period
Delirium, Dementia, Cognitive Disorders
Neurobehavioural Manifestation
Mental Competency
Drug: Hypnotics: propofol, sevoflurane, desflurane,desflurane,midazolam

Study Type: Observational
Study Design: Screening, Longitudinal, Convenience Sample, Prospective Study
Official Title: Post Operative Cognitive Recovery and Neuropsychological Complications After General Anesthesia. A Comparison Between Different Techniques of Anesthesia: A Multi-Center Observational Study

Resource links provided by NLM:


Further study details as provided by University of Roma La Sapienza:

Estimated Enrollment: 1200
Study Start Date: May 2007
  Show Detailed Description

  Eligibility

Ages Eligible for Study:   18 Years and older
Genders Eligible for Study:   Both
Accepts Healthy Volunteers:   No
Criteria

Inclusion Criteria:

  • Adult age patients undergoing general anesthesia

Exclusion Criteria:

  • Cerebral and cardiac surgery
  • Surgical procedures required postoperative delayed extubation
  Contacts and Locations
Please refer to this study by its ClinicalTrials.gov identifier: NCT00507195

Contacts
Contact: Federico Bilotta, MD, PhD 39 339 33 708 22 bilotta@tiscali.it

Locations
Italy
Azienda Policlinico Umberto I, University of Rome La Sapienza, Recruiting
Rome,, Italy, 00161
Contact: Federico Bilotta, MD, PhD            
Principal Investigator: Federico Bilotta, MD, PhD            
Sponsors and Collaborators
University of Roma La Sapienza
Investigators
Study Chair: Federico Bilotta, MD, PhD University of Roma La Sapienza
  More Information

No publications provided

Study ID Numbers: pinocchio
Study First Received: July 23, 2007
Last Updated: July 24, 2007
ClinicalTrials.gov Identifier: NCT00507195     History of Changes
Health Authority: Italy: Ethics Committee

Keywords provided by University of Roma La Sapienza:
Postanethesia cognitive recovery
Postoperative delirium
hypnotics
propofol
sevoflurane
desflurane
postoperative cognitive recovery

Study placed in the following topic categories:
Neurotransmitter Agents
Psychotropic Drugs
Anesthetics
Sevoflurane
Signs and Symptoms
Desflurane
Mental Disorders
Hypnotics and Sedatives
Propofol
Dementia
Neurobehavioral Manifestations
Delirium
Anesthetics, Intravenous
Tranquilizing Agents
Adjuvants, Immunologic
Central Nervous System Depressants
Confusion
Midazolam
Cognition Disorders
Anesthetics, Inhalation
Delirium, Dementia, Amnestic, Cognitive Disorders
Anesthetics, General
Neurologic Manifestations
Anti-Anxiety Agents
Platelet Aggregation Inhibitors

Additional relevant MeSH terms:
Neurotransmitter Agents
Molecular Mechanisms of Pharmacological Action
GABA Modulators
Hematologic Agents
Physiological Effects of Drugs
Psychotropic Drugs
Anesthetics
Sevoflurane
Desflurane
Signs and Symptoms
Mental Disorders
Therapeutic Uses
Hypnotics and Sedatives
Propofol
Neurobehavioral Manifestations
Delirium
Anesthetics, Intravenous
Tranquilizing Agents
Nervous System Diseases
Central Nervous System Depressants
Confusion
Midazolam
Cognition Disorders
Pharmacologic Actions
Adjuvants, Anesthesia
Anesthetics, Inhalation
Delirium, Dementia, Amnestic, Cognitive Disorders
Anesthetics, General
GABA Agents
Neurologic Manifestations

ClinicalTrials.gov processed this record on September 03, 2009